Vannucchi AM, Kantarjian HM, Kiladjian J-J, Gotlib J, Cervantes F, Mesa RA, Sarlis NJ, Peng W, Sandor V, Gopalakrishna P, Hmissi A, Stalbovskaya V, Gupta V, Harrison C, Verstovsek S. A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis. Haematologica [Internet]. 2015Sep.4 [cited 2026Nov.8];100(9):1139-45. Available from: https://haematologica.org/article/view/7488